gabapentin

FDA Drug Profile — GABAPENTIN, Neurontin, Gabapentin, gabapentin, Gralise

Drug Details

Generic Name
gabapentin
Brand Names
GABAPENTIN, Neurontin, Gabapentin, gabapentin, Gralise
Application Number
ANDA211314
Sponsor
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC Codes
50
Dosage Forms
CAPSULE, TABLET, FILM COATED, SOLUTION, TABLET, SUSPENSION
Routes
ORAL
Active Ingredients
GABAPENTIN

Indications and Usage

1 INDICATIONS AND USAGE Gabapentin tablets are indicated for the management of postherpetic neuralgia. Once-daily gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration. Gabapentin tablets are indicated for the management of Postherpetic Neuralgia (PHN). Important Limitation: Once-daily gabapentin tablets are not substitutable with other gabapentin products because of differing pharmacokinetic profiles that affect the frequency of administration (See Warnings and Precautions )